{"id":6874,"date":"2017-01-27T19:55:15","date_gmt":"2017-01-28T00:55:15","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/hunter-shkolnik-plaintiffs-executive-committee-invokana\/"},"modified":"2017-01-27T19:55:15","modified_gmt":"2017-01-28T00:55:15","slug":"avci-shkolnik-davacilar-yurutme-komitesi-invokana","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/avci-shkolnik-davacilar-yurutme-komitesi-invokana\/","title":{"rendered":"Invokana Davac\u0131 \u0130cra Komitesinde Hunter Shkolnik"},"content":{"rendered":"<p><em>Firma, re\u00e7ete edilen bir\u00e7ok ma\u011fduru temsil ediyor <a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/invokana\/\">Invokana<\/a>.<\/em><\/p>\n<p>\u0130\u015f Orta\u011f\u0131n\u0131 duyurmaktan gurur duyuyoruz <a href=\"\/tr\/napoli-attorney\/avci-shkolnik\/\">Avc\u0131 J. Shkolnik<\/a> y\u0131l\u0131nda Davac\u0131lar \u0130cra Kurulu \u00dcyesi olarak atanm\u0131\u015ft\u0131r. <em>In Re: Invokana (Canagliflozin) \u00dcr\u00fcnleri Sorumluluk Davas\u0131 <\/em>(MDL No. 2750) Amerika Birle\u015fik Devletleri New Jersey B\u00f6lge Mahkemesinden Birle\u015fik Devletler B\u00f6lge Yarg\u0131c\u0131 Brian R. Martinotti.<\/p>\n<p>Mahkeme t\u00fcm iddialar\u0131 g\u00f6zden ge\u00e7irdi, ancak nihayetinde &quot;farkl\u0131 ge\u00e7mi\u015flere sahip bir dizi y\u00fcksek vas\u0131fl\u0131 avukat&quot; atayarak &quot;etkili bir komite&quot; olu\u015fturmaya karar verdi. Bay Shkolnik&#039;in karma\u015f\u0131k farmas\u00f6tik davalar\u0131n\u0131 ele alma deneyimi kesinlikle bu parametrelere giriyor.<\/p>\n<p>\u0130cra Komitesinin bir \u00fcyesi olarak Bay Shkolnik, gerekli yasal belgelerin koordinasyonunu, haz\u0131rlanmas\u0131n\u0131 ve sunulmas\u0131n\u0131 denetlerken ayn\u0131 zamanda iddialar\u0131 ara\u015ft\u0131rmaya ve geli\u015ftirmeye devam edecektir.<\/p>\n<p>2015 y\u0131l\u0131nda FDA, ek ciddi g\u00fcvenlik endi\u015felerine dayal\u0131 olarak uyar\u0131s\u0131n\u0131 g\u00fc\u00e7lendirdi ve yeni bir uyar\u0131 ekledi. <em>Uyar\u0131 ve \u00d6nlem<\/em> etiket. Dava, Invokana kullan\u0131m\u0131n\u0131n b\u00f6brek yetmezli\u011fi ve kalp krizi riskinde art\u0131\u015fa yol a\u00e7abilece\u011fini iddia ediyor.<\/p>\n<blockquote><p>&quot;Bu Y\u00fcr\u00fctme Kurulu \u00fcyeleriyle \u00e7al\u0131\u015fma f\u0131rsat\u0131n\u0131 memnuniyetle kar\u015f\u0131l\u0131yorum. \u0130nsanlar, bir hastal\u0131\u011f\u0131 tedavi etmek i\u00e7in bir ila\u00e7 ald\u0131klar\u0131na ve sonunda yepyeni bir dizi ciddi sa\u011fl\u0131k sorunuyla u\u011fra\u015fmak zorunda kald\u0131klar\u0131na inan\u0131yor. Firmam ve ben, m\u00fcvekkilimizin ac\u0131 \u00e7ekmesinden sorumlu olanlar\u0131n hesap vermesi gerekti\u011fine inan\u0131yoruz ve bu m\u00fccadeleyi \u00fcstlenmeye haz\u0131r\u0131z.\u201d<br \/>\nAvc\u0131 Shkolnik<\/p><\/blockquote>\n<p>Invokana ile birlikte di\u011fer ila\u00e7lar, yaralanma ve yan etkilerle ili\u015fkilidir. Bunlar \u015funlar\u0131 i\u00e7erir, ancak bunlarla s\u0131n\u0131rl\u0131 de\u011fildir:<\/p>\n<ul>\n<li>Kanda a\u015f\u0131r\u0131 miktarda asitlik (ketoasidoz);<\/li>\n<li>Daha y\u00fcksek kemik k\u0131r\u0131\u011f\u0131 riski;<\/li>\n<li>Azalt\u0131lm\u0131\u015f besleyici kemik yo\u011funlu\u011fu;<\/li>\n<li>B\u00f6brek sorunlar\u0131;<\/li>\n<li>Kalp \u00e7arpmas\u0131;<\/li>\n<li>Y\u00fcksek kolesterol seviyeleri (hiperkalemi);<\/li>\n<li>Vajinal mantar enfeksiyonlar\u0131;<\/li>\n<li>\u0130drar yolu hastal\u0131klar\u0131; Ve<\/li>\n<li>D\u00fc\u015f\u00fck kan \u015fekeri.<\/li>\n<\/ul>\n<p>Sa\u011fl\u0131k tehlikeleri a\u015f\u0131r\u0131 ko\u015fullarda \u00f6l\u00fcme yol a\u00e7abilir ve yukar\u0131dakiler \u015fiddetlidir. Invokana ile birlikte, ilave sodyum-glikoz kotransporter-2 (SGLT2s) ila\u00e7lar\u0131n\u0131n tehlikeleri ara\u015ft\u0131r\u0131lmaktad\u0131r.<\/p>\n<p>SGLT2 veya Invokana gibi alternatif ila\u00e7lar kulland\u0131ysan\u0131z ve ila\u00e7lar\u0131n\u0131z i\u00e7in yapmad\u0131\u011f\u0131n\u0131z bir zarara u\u011frad\u0131\u011f\u0131n\u0131z\u0131 d\u00fc\u015f\u00fcn\u00fcyorsan\u0131z, ila\u00e7 \u00fcreticisine kar\u015f\u0131 dava a\u00e7abilirsiniz. Bununla birlikte, tazminat alabilmeniz i\u00e7in, Janssen Pharmaceuticals&#039;\u0131n kusurlu bir ilac\u0131 da\u011f\u0131tarak ve \u00fcreterek veya bilinen tehlikelere ili\u015fkin yeterli uyar\u0131da bulunmayarak kullan\u0131c\u0131ya kar\u015f\u0131 y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fcn\u00fc ihlal etti\u011fini ve bunun do\u011frudan bir sonucu olarak yaralanman\u0131za neden oldu\u011funu kan\u0131tlaman\u0131z gerekir. Bir avukat, yukar\u0131dakileri belirlemenize yard\u0131mc\u0131 olabilir.<\/p>\n<div class=\"paragraph-highlight\">\n<p>izle <a href=\"https:\/\/www.youtube.com\/watch?v=kmXNSqzWQ3s\" target=\"_blank\" rel=\"noopener\">bilgilendirici video<\/a> Invokana ile ilgili.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Firma, Invokana re\u00e7ete edilen bir\u00e7ok kurban\u0131 temsil ediyor. Partner Hunter J. Shkolnik&#039;in Davac\u0131lar \u0130cra Kurulu \u00dcyesi olarak se\u00e7ildi\u011fini duyurmaktan gurur duyuyoruz\u2026<\/p>","protected":false},"author":3,"featured_media":6875,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[774],"tags":[858,915],"class_list":["post-6874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-napoli-shkolnik-news","tag-hunter-shkolnik","tag-invokana-lawyer"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/6874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=6874"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/6874\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/6875"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=6874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=6874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=6874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}